210 related articles for article (PubMed ID: 20363744)
1. Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones.
Vranka JA; Pokidysheva E; Hayashi L; Zientek K; Mizuno K; Ishikawa Y; Maddox K; Tufa S; Keene DR; Klein R; Bächinger HP
J Biol Chem; 2010 May; 285(22):17253-62. PubMed ID: 20363744
[TBL] [Abstract][Full Text] [Related]
2. Severe osteogenesis imperfecta in cyclophilin B-deficient mice.
Choi JW; Sutor SL; Lindquist L; Evans GL; Madden BJ; Bergen HR; Hefferan TE; Yaszemski MJ; Bram RJ
PLoS Genet; 2009 Dec; 5(12):e1000750. PubMed ID: 19997487
[TBL] [Abstract][Full Text] [Related]
3. PPIB mutations cause severe osteogenesis imperfecta.
van Dijk FS; Nesbitt IM; Zwikstra EH; Nikkels PG; Piersma SR; Fratantoni SA; Jimenez CR; Huizer M; Morsman AC; Cobben JM; van Roij MH; Elting MW; Verbeke JI; Wijnaendts LC; Shaw NJ; Högler W; McKeown C; Sistermans EA; Dalton A; Meijers-Heijboer H; Pals G
Am J Hum Genet; 2009 Oct; 85(4):521-7. PubMed ID: 19781681
[TBL] [Abstract][Full Text] [Related]
4. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex.
Chang W; Barnes AM; Cabral WA; Bodurtha JN; Marini JC
Hum Mol Genet; 2010 Jan; 19(2):223-34. PubMed ID: 19846465
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues.
Homan EP; Lietman C; Grafe I; Lennington J; Morello R; Napierala D; Jiang MM; Munivez EM; Dawson B; Bertin TK; Chen Y; Lua R; Lichtarge O; Hicks J; Weis MA; Eyre D; Lee BH
PLoS Genet; 2014 Jan; 10(1):e1004121. PubMed ID: 24465224
[TBL] [Abstract][Full Text] [Related]
6. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.
Marini JC; Cabral WA; Barnes AM
Cell Tissue Res; 2010 Jan; 339(1):59-70. PubMed ID: 19862557
[TBL] [Abstract][Full Text] [Related]
7. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.
Morello R; Bertin TK; Chen Y; Hicks J; Tonachini L; Monticone M; Castagnola P; Rauch F; Glorieux FH; Vranka J; Bächinger HP; Pace JM; Schwarze U; Byers PH; Weis M; Fernandes RJ; Eyre DR; Yao Z; Boyce BF; Lee B
Cell; 2006 Oct; 127(2):291-304. PubMed ID: 17055431
[TBL] [Abstract][Full Text] [Related]
8. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.
Valli M; Barnes AM; Gallanti A; Cabral WA; Viglio S; Weis MA; Makareeva E; Eyre D; Leikin S; Antoniazzi F; Marini JC; Mottes M
Clin Genet; 2012 Nov; 82(5):453-9. PubMed ID: 21955071
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modifications in type I collagen from different tissues extracted from wild type and prolyl 3-hydroxylase 1 null mice.
Pokidysheva E; Zientek KD; Ishikawa Y; Mizuno K; Vranka JA; Montgomery NT; Keene DR; Kawaguchi T; Okuyama K; Bächinger HP
J Biol Chem; 2013 Aug; 288(34):24742-52. PubMed ID: 23861401
[TBL] [Abstract][Full Text] [Related]
11. Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development.
Marini JC; Cabral WA; Barnes AM; Chang W
Cell Cycle; 2007 Jul; 6(14):1675-81. PubMed ID: 17630507
[TBL] [Abstract][Full Text] [Related]
12. Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype.
Tonelli F; Cotti S; Leoni L; Besio R; Gioia R; Marchese L; Giorgetti S; Villani S; Gistelinck C; Wagener R; Kobbe B; Fiedler IAK; Larionova D; Busse B; Eyre D; Rossi A; Witten PE; Forlino A
Matrix Biol; 2020 Aug; 90():40-60. PubMed ID: 32173581
[TBL] [Abstract][Full Text] [Related]
13. Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification?
Hudson DM; Eyre DR
Connect Tissue Res; 2013; 54(4-5):245-51. PubMed ID: 23772978
[TBL] [Abstract][Full Text] [Related]
14. [Mutations of noncollagen genes in osteogenesis imperfecta--implications of the gene products in collagen biosynthesis and pathogenesis of disease].
Galicka A
Postepy Hig Med Dosw (Online); 2012 Jun; 66():359-71. PubMed ID: 22706122
[TBL] [Abstract][Full Text] [Related]
15. Generalized connective tissue disease in Crtap-/- mouse.
Baldridge D; Lennington J; Weis M; Homan EP; Jiang MM; Munivez E; Keene DR; Hogue WR; Pyott S; Byers PH; Krakow D; Cohn DH; Eyre DR; Lee B; Morello R
PLoS One; 2010 May; 5(5):e10560. PubMed ID: 20485499
[TBL] [Abstract][Full Text] [Related]
16. P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA.
Hudson DM; Weis M; Rai J; Joeng KS; Dimori M; Lee BH; Morello R; Eyre DR
J Biol Chem; 2017 Mar; 292(9):3877-3887. PubMed ID: 28115524
[TBL] [Abstract][Full Text] [Related]
17. Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP.
Amor IM; Rauch F; Gruenwald K; Weis M; Eyre DR; Roughley P; Glorieux FH; Morello R
Am J Med Genet A; 2011 Nov; 155A(11):2865-70. PubMed ID: 21964860
[TBL] [Abstract][Full Text] [Related]
18. Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations.
Hudson DM; Joeng KS; Werther R; Rajagopal A; Weis M; Lee BH; Eyre DR
J Biol Chem; 2015 Mar; 290(13):8613-22. PubMed ID: 25645914
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive
Zhytnik L; Duy BH; Eekhoff M; Wisse L; Pals G; Reimann E; Kõks S; Märtson A; Maugeri A; Maasalu K; Micha D
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327962
[TBL] [Abstract][Full Text] [Related]
20. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.
Baldridge D; Schwarze U; Morello R; Lennington J; Bertin TK; Pace JM; Pepin MG; Weis M; Eyre DR; Walsh J; Lambert D; Green A; Robinson H; Michelson M; Houge G; Lindman C; Martin J; Ward J; Lemyre E; Mitchell JJ; Krakow D; Rimoin DL; Cohn DH; Byers PH; Lee B
Hum Mutat; 2008 Dec; 29(12):1435-42. PubMed ID: 18566967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
